This announcement is a separate document:
富祥药业：2023年度以简易程序向特定对象发行股票方案论证分析报告（修订稿）
Fuxiang Pharmaceutical: Verification and Analysis Report on the 2023 Stock Issuance Plan to Specific Targets Using Simple Procedures (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.